Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

CERILLIANT™ Lacosamide-13C, D3 Solution, 100 μg/mL in Acetonitrile, Sold by MilliporeSigma™ Supelco™

Certified reference material

Manufacturer:  MilliporeSigma Supelco L0271ML

Catalog No. 01-001-538


Due to product restrictions, please to purchase or view availability for this product.


Description

Description

Lacosamide is a new antiepileptic drug approved by the FDA in late 2008 for the treatment of partial-onset seizures and diabetic neuropathic pain. The drug is marketed under the trade name Vimpat™. This internal standard is suitable for lacosamide testing methods by LC/MS or GC/MS for clinical toxicology, forensic analysis, or urine drug testing.
Specifications

Specifications

75-05-8
2°C (35.6°F) - closed cup
13CC12D3H15N2O3
1 mL
UN 1648 3 / PGII
100 μg/mL in acetonitrile
254.30
Ampule
-20°C
Safety and Handling

Safety and Handling

H332-H319

H312

EINECSNumber : 200-835-2

SDS
Documents
Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit

CERILLIANT is a registered trademark of Cerilliant Corporation